penicillamine has been researched along with ALS - Amyotrophic Lateral Sclerosis in 10 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (70.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zaleska, B | 1 |
| Conradi, S | 1 |
| Ronnevi, LO | 1 |
| Nise, G | 1 |
| Vesterberg, O | 1 |
| Wiedau-Pazos, M | 1 |
| Goto, JJ | 1 |
| Rabizadeh, S | 1 |
| Gralla, EB | 1 |
| Roe, JA | 1 |
| Lee, MK | 1 |
| Valentine, JS | 1 |
| Bredesen, DE | 1 |
| Hottinger, AF | 1 |
| Fine, EG | 1 |
| Gurney, ME | 1 |
| Zurn, AD | 1 |
| Aebischer, P | 1 |
| Gabbianelli, R | 1 |
| Ferri, A | 1 |
| Rotilio, G | 1 |
| Carrì, MT | 1 |
| Bousser, MG | 1 |
| Malier, M | 1 |
| Jusić, A | 1 |
| Sostarko, M | 1 |
| Majić, D | 1 |
| Check, WA | 1 |
| Boothby, JA | 1 |
| DeJesus, PV | 1 |
| Rowland, LP | 1 |
| Currier, RD | 1 |
| Haerer, AF | 1 |
1 review available for penicillamine and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
[Progress in the treatment of degenerative diseases of the nervous system. Selected problems].
Topics: Amyotrophic Lateral Sclerosis; Antiparkinson Agents; Humans; Huntington Disease; Lithium; Neostigmin | 1980 |
9 other studies available for penicillamine and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Long-time penicillamine-treatment in amyotrophic lateral sclerosis with parallel determination of lead in blood, plasma and urine.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Drug Therapy, Combination; Female; Humans; Lead; Male; M | 1982 |
Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Apoptosis; Binding Sites; Catalysis; Cell Line; Chelating Ag | 1996 |
The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Brain Stem; Cell Count; Chelating Agents; Copper; Facial Ner | 1997 |
Aberrant copper chemistry as a major mediator of oxidative stress in a human cellular model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Blotting, Western; Catalase; Cell Survival; Copper; Humans; Neuroblas | 1999 |
Penicillamine in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Drug Evaluation; Female; Humans; Male; Penicillamine | 1979 |
[Spinal amyotrophy, delta-aminolevulinic acid and Metalcaptase (preliminary communication)].
Topics: Adult; Aged; Aminolevulinic Acid; Amyotrophic Lateral Sclerosis; Female; Humans; Levulinic Acids; Ma | 1979 |
Amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Humans; Lead; Neurotoxins; Penicillamine | 1979 |
Reversible forms of motor neuron disease. Lead "neuritis".
Topics: Adult; Amyotrophic Lateral Sclerosis; Blood Urea Nitrogen; Diagnosis, Differential; Electromyography | 1974 |
Amyotrophic lateral sclerosis and metallic toxins.
Topics: Adult; Aged; Agricultural Workers' Diseases; Amyotrophic Lateral Sclerosis; Arsenic; Chelating Agent | 1968 |